Genetic aspects of type 1 glucagon peptide agonists clinical efficacy: A review von Golovina, E L, Grishkevich, I R, Vaizova, O E, Samoilova, I G, Podchinenova, D V, Matveeva, M V, Kudlay, D A

Volltext

Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review von Golovina, E L, Vaizova, O E, Meleshko, M V, Samoilova, I G, Podchinenova, D V, Borozinets, A A, Matveeva, M V, Kudlay, D A

Volltext

Pharmacogenetics of dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes mellitus: A review von Samoilova, Iuliia G., Vaizova, Olga E., Stankova, Anastasia E., Matveeva, Mariia V., Podchinenova, Daria V., Kudlay, Dmitry A., Borozinets, Anastasiia A., Filippova, Tatyana A., Grishkevich, Ivan R., Partala, Anastasia V., Gerasimova, Diana A.

Volltext

Clinical Significance and Patterns of Potential Drug-Drug Interactions in Cardiovascular Patients: Focus on Low-Dose Aspirin and Angiotensin-Converting Enzyme Inhibitors von Anfinogenova, Nina D, Stepanov, Vadim A, Chernyavsky, Alexander M, Karpov, Rostislav S, Efimova, Elena V, Novikova, Oksana M, Trubacheva, Irina A, Falkovskaya, Alla Y, Maksimova, Aleksandra S, Ryumshina, Nadezhda I, Shelkovnikova, Tatiana A, Ussov, Wladimir Y, Vaizova, Olga E, Popov, Sergey V, Repin, Alexei N

Volltext

METHOD FOR MODELLING CEREBRAL ISCHEMIA DISEASE AGGRAVATED BY HEMISPHERE ASYMMETRY PHENOMENA von SUSLOV NIKOLAJ I, PLOTNIKOV MARK B, VAIZOVA OLGA E

Volltext bestellen